Wang Ningli
首页 > 学术活动 > 专家风采

Wang Ningli

Prof. Wang Ningli serves as the Director of Beijing Tongren Eye Center, Dean of School of Ophthalmology, Capital Medical University, Head of National Committee for the Prevention of Blindness, President-elect of Asia-Pacific Academy of Ophthalmology (APAO), President of Chinese Ophthalmologist Association, Chair LXXIV of Academia Ophthalmologica Internationalis, Council Member of World Glaucoma Association, Board Member, Asia-Pacific Glaucoma Society, Emeritus Group Member of International Council of Ophthalmology.

 He has engaged in clinical and scientific research in ophthalmology for 35 years, and performed more than 20,000 surgeries. He currently serves as a consultant expert in Central Health Care Committee. The main areas of his works are: the pathogenesis and diagnosis and treatment of glaucoma. He is the Director of Beijing Tongren Eye Center (Key Discipline of the Ministry of Education and Clinical Key Specialty of National Health and Family Planning Commission), and Director of the National Engineering Research Center for Ophthalmic Equipments. He served as primary investigator (PI) of 12 major projects, including National High-tech R&D Program (863 Program), Key Program of National Natural Science Foundation of China (NSFC), NSFC Projects of International Cooperation and Exchange, Major Project of the Ministry of Science and Technology of China. Besides that, he has led 2 national major blindness prevention projects. Prof. Wang has by now served as supervisor for 11 postdoctoral students and 53 doctoral students.

He has published 429 peer-review papers as the first author or corresponding author, including 167 SCI articles, with 5388 citations in total and 4765 citations by others. Among his publications, 25 papers are published on articles (first author or corresponding author) the top two international ophthalmology journals; 4 papers are published on Nature Genetics and 1 paper on Nature Communication. In terms of the number of articles published in the glaucoma field, he ranks the first in China and top 10 worldwide.  He is the chief-editor of 26 textbooks and monographs on ophthalmology and 12 standard specifications, and has been authorized 20 patents. As PI, he was awarded 2 National Science and Technology Progress Second Class Awards and 4 Provincial Science and Technology Progress First Class Awards. He was listed as Elsevier’s: “Most Cited Chinese Researchers” in 2014, 2015 and 2016, and The Ophthalmologist's “Top 100 most influential people in the world of ophthalmology” in 2014 and 2016).

 Prof. Wang was awarded Zhou Guangzhao Foundation Award for Science and Technology (2014) and Medical Doctor Award of Chinese Medical Doctor Association (2010), and was honored Young and Middle-aged Experts with Outstanding Contributions and The National Model Worker (2015). During his term as the President of Chinese Ophthalmological Society, he greatly promoted the international cooperation and exchange activities and increased the international influence of Chinese ophthalmic community, and thus was awarded Outstanding Achievement Award by Chinese Ophthalmological Society and 5 international awards. He led and participated in several major blindness prevention projects, including the “Sight Action”, and was awarded the National Award for Outstanding Contribution to Blindness Prevention.